These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy. Kan HE; Scheenen TW; Wohlgemuth M; Klomp DW; van Loosbroek-Wagenmans I; Padberg GW; Heerschap A Neuromuscul Disord; 2009 May; 19(5):357-62. PubMed ID: 19329315 [TBL] [Abstract][Full Text] [Related]
12. Wnt/Frizzled signaling in the vasculature: new angiogenic factors in sight. Masckauchán TN; Kitajewski J Physiology (Bethesda); 2006 Jun; 21():181-8. PubMed ID: 16714476 [TBL] [Abstract][Full Text] [Related]
13. FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients. Rijkers T; Deidda G; van Koningsbruggen S; van Geel M; Lemmers RJ; van Deutekom JC; Figlewicz D; Hewitt JE; Padberg GW; Frants RR; van der Maarel SM J Med Genet; 2004 Nov; 41(11):826-36. PubMed ID: 15520407 [TBL] [Abstract][Full Text] [Related]
14. FSHD region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy. Wuebbles RD; Hanel ML; Jones PL Dis Model Mech; 2009; 2(5-6):267-74. PubMed ID: 19383939 [TBL] [Abstract][Full Text] [Related]
15. All muscle satellite cells are equal, but are some more equal than others? Zammit PS J Cell Sci; 2008 Sep; 121(Pt 18):2975-82. PubMed ID: 18768931 [TBL] [Abstract][Full Text] [Related]
16. [Facioscapulohumeral muscular dystrophy. The spectrum of clinical manifestations and molecular genetic changes]. Krasnianski M; Neudecker S; Eger K; Schulte-Mattler W; Zierz S Nervenarzt; 2003 Feb; 74(2):151-8. PubMed ID: 12596016 [TBL] [Abstract][Full Text] [Related]
17. Facioscapulohumeral muscular dystrophy: do neurotrophins play a role? Angelucci F; Colantoni L Muscle Nerve; 2010 Jan; 41(1):120-7. PubMed ID: 19813193 [TBL] [Abstract][Full Text] [Related]
18. Alteration of expression of muscle specific isoforms of the fragile X related protein 1 (FXR1P) in facioscapulohumeral muscular dystrophy patients. Davidovic L; Sacconi S; Bechara EG; Delplace S; Allegra M; Desnuelle C; Bardoni B J Med Genet; 2008 Oct; 45(10):679-85. PubMed ID: 18628314 [TBL] [Abstract][Full Text] [Related]
20. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q. Jiang G; Yang F; van Overveld PG; Vedanarayanan V; van der Maarel S; Ehrlich M Hum Mol Genet; 2003 Nov; 12(22):2909-21. PubMed ID: 14506132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]